Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database

Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database

AbstractIntroduction The aim of this study is to assess the outcomes of different induction therapies among mild to moderate immunological risk kidney transplants in the era tacrolimus and mycophenolate-derivate based maintenance.Methods This was a retrospective cohort study using data from the Unit...

Full description

Bibliographic Details
Main Authors: Hatem Ali, Mahmoud Mohammed, Tibor Fülöp, Shafi Malik
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
Induction therapy
renal transplant
kidney transplant
outcomes
high risk
HLA
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2215536

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2023.2215536

Similar Items